NCT02804113View on ClinicalTrials.gov

Clinical Trial Investigating the Efficacy of the Supera Peripheral Stent System for the Treatment of the Common Femoral Artery

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 25, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

October 30, 2019

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Supera Peripheral Stent System

Trial Locations (7)

2060

ZNA Stuivenberg, Antwerp

2820

Imelda Hospital, Bonheiden

9200

AZ Sint-Blasius, Dendermonde

9300

OLV Ziekenhuis Aalst, Aalst

44093

CHU de Nantes, Nantes

63003

CHU de Clermont-Ferrand, Clermont-Ferrand

84000

Clinique Rhone Durance, Avignon

Sponsors

Lead Sponsor

ID3 Medical
All Listed Sponsors
lead

ID3 Medical

OTHER

NCT02804113 - Clinical Trial Investigating the Efficacy of the Supera Peripheral Stent System for the Treatment of the Common Femoral Artery | Biotech Hunter | Biotech Hunter